Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease
Category: News
The US sees around 476,000 new Lyme cases every year
Anaphylaxis is the most serious type of allergic reaction and occurs more commonly in boys
CER‑T therapy shows initial safety signals and prompts protocol expansion
Trial to assess whether once‑weekly treatment can reduce symptomatic viral respiratory infections
siRNA therapeutic progresses in global study for patients with elevated Lp(a)
Company strengthens pipeline with AKTX-102 as it broadens its intellectual property estate
Initiative focuses on population-specific molecular profiling
Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati
Dawnzera showed an 81% reduction in the four-weekly rate of HAE attacks compared to placebo